Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:684-690

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weintraub, N. L.
Right arrow Articles by Lonigro, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weintraub, N. L.
Right arrow Articles by Lonigro, A. J.

(Hypertension. 1995;26:684-690.)
© 1995 American Heart Association, Inc.


Articles

Relationship of Arachidonic Acid Release to Porcine Coronary Artery Relaxation

Neal L. Weintraub; Alan H. Stephenson; Randy S. Sprague; Lorraine McMurdo; Andrew J. Lonigro

From the Departments of Internal Medicine (N.L.W., R.S.S., L.M., A.J.L.) and Pharmacological and Physiological Science (A.H.S., A.J.L.), St Louis (Mo) University School of Medicine.

Correspondence to Neal L. Weintraub, MD, St Louis University School of Medicine, Division of Clinical Pharmacology, Room M205, 1402 S Grand Blvd, St Louis, MO 63104.

Abstract In porcine coronary artery endothelium-dependent relaxation to bradykinin is in part attributed to a chemically unidentified factor, termed endothelium-derived hyperpolarizing factor (EDHF). We hypothesize that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production. To define the relationship between EDHF production and arachidonic acid release, we investigated the role of phospholipase C in bradykinin-induced relaxation and prostaglandin I2 production (an index of arachidonic acid release) in porcine coronary artery. The phospholipase C inhibitor U73122 (1 µmol/L) abolished bradykinin-induced, nitric oxide–mediated relaxation but did not inhibit either bradykinin-induced, EDHF-mediated relaxation or prostaglandin I2 production. However, when given at a larger dose (20 µmol/L) U73122 abolished both bradykinin-induced, EDHF-mediated relaxation and prostaglandin I2 production. Similarly, the calcium-ATPase inhibitor thapsigargin, given at a dose (1 µmol/L) that abolished bradykinin-induced increases in intracellular calcium concentration in cultured porcine coronary artery endothelial cells, eliminated both bradykinin-induced, EDHF-mediated relaxation and prostaglandin I2 production. Although thapsigargin abolished bradykinin-induced prostaglandin I2 production, the basal production of prostaglandin I2 was enhanced, and contraction of endothelium-intact rings was attenuated. These latter responses are most likely related to enhanced basal arachidonic acid release and associated EDHF production. These observations suggest that phospholipase C activation and increased intracellular calcium concentration are required for both bradykinin-induced arachidonic acid release and EDHF production in porcine coronary artery. Moreover, EDHF production in porcine coronary artery appears to be closely associated with arachidonic acid release, thus supporting the hypothesis that arachidonic acid, acting through a cyclooxygenase-independent mechanism, is responsible for EDHF production in porcine coronary artery.


Key Words: endothelium-derived factors • epoprostenol • nitric oxide • phospholipase C • arachidonic acid • arteries • phospholipases A




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff
Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. L. Stoll, G. M. Denning, W.-G. Li, J. B. Rice, A. L. Harrelson, S. A. Romig, S. T. Gunnlaugsson, F. J. Miller Jr, and N. L. Weintraub
Regulation of Endotoxin-Induced Proinflammatory Activation in Human Coronary Artery Cells: Expression of Functional Membrane-Bound CD14 by Human Coronary Artery Smooth Muscle Cells
J. Immunol., July 15, 2004; 173(2): 1336 - 1343.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zhang, T. Tazzeo, S. Hirota, and L. J. Janssen
Vasodilatory and Electrophysiological Actions of 8-iso-Prostaglandin E2 in Porcine Coronary Artery
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1054 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Marrelli
Mechanisms of endothelial P2Y1- and P2Y2-mediated vasodilatation involve differential [Ca2+]i responses
Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1759 - H1766.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. H. Zink, C. L. Oltman, T. Lu, P. V. G. Katakam, T. L. Kaduce, H.-C. Lee, K. C. Dellsperger, A. A. Spector, P. R. Myers, and N. L. Weintraub
12-Lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H693 - H704.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Qiu and J. Quilley
Vascular effects of arachidonic acid in the rat perfused heart: role of the endothelium, cyclooxygenase, cytochrome P450, and K+ channels
J. Lipid Res., December 1, 1999; 40(12): 2177 - 2184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. L. Weintraub, X. Fang, T. L. Kaduce, M. VanRollins, P. Chatterjee, and A. A. Spector
Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2098 - H2108.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. G. Clark and L. C. Fuchs
Role of Nitric Oxide and Ca++-Dependent K+ Channels in Mediating Heterogeneous Microvascular Responses to Acetylcholine in Different Vascular Beds
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1473 - 1479.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
N. L. Weintraub, X. Fang, T. L. Kaduce, M. VanRollins, P. Chatterjee, and A. A. Spector
Potentiation of Endothelium-Dependent Relaxation by Epoxyeicosatrienoic Acids
Circ. Res., August 19, 1997; 81(2): 258 - 267.
[Abstract] [Full Text]


Home page
CirculationHome page
J. Bauersachs, R. Popp, M. Hecker, E. Sauer, I. Fleming, and R. Busse
Nitric Oxide Attenuates the Release of Endothelium-Derived Hyperpolarizing Factor
Circulation, December 15, 1996; 94(12): 3341 - 3347.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. V. Smirnov and P. I. Aaronson
Modulatory Effects of Arachidonic Acid on the Delayed Rectifier K+ Current in Rat Pulmonary Arterial Myocytes: Structural Aspects and Involvement of Protein Kinase C
Circ. Res., July 1, 1996; 79(1): 20 - 31.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. B. Brosnihan, P. Li, and C. M. Ferrario
Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
Hypertension, March 1, 1996; 27(3): 523 - 528.
[Abstract] [Full Text]